Business · 09/09/2026Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Vaccines and Related Biological Products Advisory Committee for 2027 Southern Hemisphere Influenza Virus Vaccines
Summary
The FDA is hosting a public advisory committee meeting to gather input on the development of 2027 Southern Hemisphere influenza vaccines, with the goal of informing regulatory decisions and ensuring public safety.
Original source language: Federal Register — Health and Human ServicesOpen original release →